Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.41 - $8.95 $1.33 Million - $3.5 Million
-391,024 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.78 - $15.31 $1.07 Million - $2.1 Million
-137,418 Reduced 26.0%
391,024 $3.21 Million
Q4 2021

Feb 14, 2022

BUY
$14.25 - $23.53 $636,675 - $1.05 Million
44,679 Added 9.24%
528,442 $7.86 Million
Q3 2021

Nov 12, 2021

BUY
$16.88 - $22.38 $943,997 - $1.25 Million
55,924 Added 13.07%
483,763 $9.14 Million
Q2 2021

Aug 13, 2021

BUY
$18.03 - $23.82 $2.48 Million - $3.27 Million
137,421 Added 47.32%
427,839 $7.95 Million
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $5.89 Million - $8 Million
290,418 New
290,418 $6.61 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $136M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.